Aliso Viejo, CA, United States of America

Angel Padilla

USPTO Granted Patents = 4 

 

 

Average Co-Inventor Count = 2.2

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2014-2020

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations by Angel Padilla

Introduction

Angel Padilla is a notable inventor based in Aliso Viejo, California. She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions and formulations. With a total of four patents to her name, her work has had a considerable impact on ocular treatments.

Latest Patents

Among her latest patents, Angel Padilla has developed novel compositions that include bepotastine besilate and a corticosteroid. These compositions also feature at least about 0.008% w/v benzalkonium chloride and hydroxypropylmethyl cellulose E15 LV. Additionally, she has worked on formulations and methods that enhance bromfenac penetration into ocular tissue when topically administered. This innovation provides a significant improvement over the currently available BROMDAY™ formulation, while maintaining the convenience of once-daily administration and reducing the bromfenac concentration dosed to patients.

Career Highlights

Throughout her career, Angel Padilla has been associated with prominent companies in the pharmaceutical industry, including Bausch & Lomb Pharma Holdings Corp. and Bausch & Lomb Incorporated. Her work has been instrumental in advancing ocular therapies and improving patient outcomes.

Collaborations

Angel has collaborated with notable professionals in her field, including George Baklayan and Mark Barry Abelson. These partnerships have contributed to her success and the development of her innovative patents.

Conclusion

Angel Padilla's contributions to the field of pharmaceuticals through her innovative patents demonstrate her commitment to improving ocular treatments. Her work continues to influence the industry and enhance patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…